spacer
home > ebr > spring 2002 > donation of organs and tissues - new legislation in finland on the prerequisites for medical research
PUBLICATIONS
European Biopharmaceutical Review

Donation of Organs and Tissues - New Legislation in Finland on the Prerequisites for Medical Research

The protection of and right to human organs, tissues and genomics in medical research is an increasingly discussed topic and it gives rise not only to reforms of legislation but also to ethical debate. The ratification of the Convention of Human Rights and Biomedicine (1) in 1997 required some changes to the then existing legislation in Finland, but at the same time it was considered necessary to reform the legislation on human organs and tissues in medical research as a whole. In addition, other international conventions, such as the United Nations Convention on Civil and Political Rights (2), put pressure on the national legislation of human organs and tissues in medical research.The most recent considerable reform in Finland in relation to biosciences law was the introduction of the Act on Medical Use of Human Organs and Tissues in 2001. The new legislation will certainly influence the future of the medical use of human organs and tissues in Finland, both from a contractual and a practical point of view.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Rainer Hilli, Partner, and Liisa Laurila, Lawyer, at Roschier Holmberg, Attorneys Ltd

Rainer Hilli is a Partner at Roschier Holmberg and is responsible for the company's technology, media and competition group, specialising mainly in matters relating to copyright, patents, trademarks, designs, computer law, telecommunications law, media law, market law and the life sciences.
Rainer's experience includes multi-jurisdictional IP litigation and IP-driven acquisitions. He is a frequent speaker and writer of articles in the field of intellectual property.
Liisa Laurila, MSc (Econ), LLM, works as a Lawyer for Roschier Holmberg in the technology, media and competition practice group. Liisa is a member of the firm's pharmaceutical and biosciences specialist team.
She advises on copyright and trademarks as well as on general corporate matters. Liisa specialises in data protection and life sciences law, and her working languages are Finnish, Swedish and English.

spacer
Rainer Hilli
spacer
spacer
spacer
Liisa Laurila
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its steady growth.

According to the data obtained by WACD, the international air cargo information provider, in May; Turkish Cargo, the global air cargo brand providing service to 124 countries around the world, increased its tonnage rate by 7.1 percent, and grew substantially across the industry which shrank by 5.1 percent in the global air cargo market.
More info >>

White Papers

Assessing the Integrity of Pharmaceutical Packaging Using the Sepha Blisterscan and Conventional Blue Dye Leak Testing Methods

Sepha Limited

A new whitepaper by a leading packaging expert from the University of Ulster, Dr Dorian Dixon, into the integrity of pharmaceutical packaging has established that existing methods for testing the seal integrity of blister packs are not as accurate as newer, technology based test equipment.
More info >>

 
Industry Events

ELRIG Drug Discovery 2019 – Looking Back to the Future

5-6 November 2019, ACC, Liverpool

Now in its 13th year, ELRIG’s flagship conference Drug Discovery 2019 will take place at ACC in Liverpool. This year’s focus, ‘A Look Back to the Future’ is planned to include plenary introductions assessing how we got to where we are now and setting the challenges for discovering the drugs of the future. These will be followed by cutting edge talks and examples of new directions in drug discovery. Our scientific programme will feature over 40 world-class speakers with 6 main session tracks. In partnership with key academic and charitable groups, we will also run joint disease and biology-oriented tracks focusing on the basic sciences that underpin successful drug discovery.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement